Out-Of-Pocket Cost

Although the prevalence of Americans with health insurance coverage grew from 1998 to 2017, the prevalence of people who reported being unable to visit a physician due to cost also increased, according to a study published in JAMA Internal Medicine.

Differentiating patients with inflammatory bowel disease who have lost response to a biologic used to be considered a “gray zone,” according to Sushama Gundlapalli, MD, MS, a board-certified gastroenterologist at Suburban Gastroenterology Ltd. in Naperville, Illinois.